Featured Publication: Community-Driven Partnerships with Community-Engaged Research Teams Bring Resources and Reliable Information to Baltimore Residents
Community-Driven Partnerships with Community-Engaged Research Teams Bring Resources and Reliable Information to Baltimore Residents This case study presents an analysis of community-driven partnerships, focusing
Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers
A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study
Johns Hopkins Medicine Study Expands Understanding of How Fecal Microbiota Transplants May Work to Restore Gut Health
In a novel study that identified male chromosome genetic material in the intestines of female patients undergoing fecal transplants, researchers at Johns Hopkins Medicine say
Scientists Determine Why Some Patients Don’t Respond Well to Wet Macular Degeneration Treatment, Show How New Experimental Drug Can Bridge Gap
A new study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age-related macular degeneration (or “wet” AMD)
How Hypoxia Helps Cancer Spread
Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they’ve escaped the low-oxygen
Computational Tool Developed to Predict Immunotherapy Outcomes for Patients with Metastatic Breast Cancer
Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to assess which patients with metastatic
Johns Hopkins Breaks Ground on Building Named in Honor of Henrietta Lacks
University and health system leaders were joined by members of the Lacks family and elected officials Monday to officially kick off an East Baltimore building
Lymph Node-Like Structures May Trigger the Demise of Cancer Tumors
A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to successfully treating patients with hepatocellular
Funding Opportunity! Apply for a Johns Hopkins and Kaiser Permanente Research Collaboration Pilot Award by December 18
The Johns Hopkins and Kaiser Permanente Research Collaboration Committee seeks to fund research projects highlighting the effective synergy of the Johns Hopkins Medicine and Kaiser Permanente collaboration in tackling the complex and intriguing questions vexing both health systems.
ICTR Deputy Directors Christopher Chute, MD, DrPH, and Jeffrey Rothstein, MD, PhD Elected to National Academy of Medicine
Johns Hopkins University faculty members Christopher G. Chute and Jeffrey D. Rothstein are among 100 scholars newly elected to the National Academy of Medicine, announced during the NAM’s annual meeting in
Johns Hopkins ALACRITY Center Announces New Pilot Funding
The Johns Hopkins ALACRITY Center for Health and Longevity in Mental Illness, funded by a NIMH P50, is pleased to announce requests for proposals for our 2025 Pilot Grant Program.
Call for Applications: Clinical Research Scholars Program (K12)
2025 Clinical Research Scholars Program (K12) Information Session: Thursday, October 31, 2024 | Noon-1:00 pm Register Application Deadline: Friday, December 13, 2024 View K12 Information
Immune Signatures May Predict Adverse Events in Patients Taking Immunotherapy
Distinct immune “signatures” in patients who develop adverse events while taking immunotherapy for cancer may help oncologists identify patients at risk and treat them early
Event Honors NIH Partnership with Voices For Our Fathers Legacy Foundation
Article Courtesy of Eric Bock | NIH Record NIH recently debuted a plaque honoring the memory of the African American men unethically treated in the
